In addition, ER + BC cells grown under estrogen-free conditions presented an upregulation of PD-L1 as a result of ERα signaling abrogation [81], corroborating the possibility of combining NET with immunotherapy in ER + BC. Here, ESR1 is linked to breast cancer.